Alagille Syndrome Market: Epidemiology, In-Market Drugs, and Pipeline Therapies: This report provides a detailed look at the epidemiology of ALGS, including its prevalence (approximately 1 in 70,000 to 100,000 live births). It analyzes existing treatments like ursodeoxycholic acid and bile acid inhibitors (maralixibat and odevixibat), and provides an overview of drugs in the developme... https://www.marketresearchfuture.com/reports/alagille-syndrome-market-6324